[go: up one dir, main page]

MX2019005383A - Formulaciones antimicrobianas para el tratamiento de infecciones veterinarias de pezuña. - Google Patents

Formulaciones antimicrobianas para el tratamiento de infecciones veterinarias de pezuña.

Info

Publication number
MX2019005383A
MX2019005383A MX2019005383A MX2019005383A MX2019005383A MX 2019005383 A MX2019005383 A MX 2019005383A MX 2019005383 A MX2019005383 A MX 2019005383A MX 2019005383 A MX2019005383 A MX 2019005383A MX 2019005383 A MX2019005383 A MX 2019005383A
Authority
MX
Mexico
Prior art keywords
treatment
pezuña
composition
antimicrobial formulations
biphasic system
Prior art date
Application number
MX2019005383A
Other languages
English (en)
Inventor
Kerr Michael
Allen Teresa
Original Assignee
Provita Eurotech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Provita Eurotech Ltd filed Critical Provita Eurotech Ltd
Publication of MX2019005383A publication Critical patent/MX2019005383A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/11—Aldehydes
    • A61K31/115—Formaldehyde
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/02—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests containing liquids as carriers, diluents or solvents
    • A01N25/04—Dispersions, emulsions, suspoemulsions, suspension concentrates or gels
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N31/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
    • A01N31/02—Acyclic compounds
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/02—Saturated carboxylic acids or thio analogues thereof; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/34—Copper; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Inorganic Chemistry (AREA)
  • Environmental Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Se proporciona una composición que comprende un material orgánico y al menos un primer agente tensioactivo que, después de la adición de una solución acuosa a la composición, puede formar un sistema bifásico, en donde el sistema bifásico es útil para el tratamiento de, o la prevención de infecciones de pezuña. También se proporciona un sistema bifásico útil para el tratamiento de, o la prevención de infecciones de pezuña, en donde el sistema bifásico comprende la composición y una fase acuosa en donde la composición se dispersa como gotas dentro de la fase acuosa.
MX2019005383A 2016-11-09 2017-11-09 Formulaciones antimicrobianas para el tratamiento de infecciones veterinarias de pezuña. MX2019005383A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB201618945 2016-11-09
PCT/GB2017/053382 WO2018087554A1 (en) 2016-11-09 2017-11-09 Antimicrobial formulations for the improved treatment of veterinary hoof infections

Publications (1)

Publication Number Publication Date
MX2019005383A true MX2019005383A (es) 2019-09-04

Family

ID=60331657

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2019005383A MX2019005383A (es) 2016-11-09 2017-11-09 Formulaciones antimicrobianas para el tratamiento de infecciones veterinarias de pezuña.

Country Status (11)

Country Link
US (2) US11344508B2 (es)
EP (1) EP3538072A1 (es)
JP (1) JP7058648B2 (es)
CN (1) CN110225746A (es)
CL (1) CL2019001260A1 (es)
GB (1) GB2571235B (es)
MX (1) MX2019005383A (es)
NZ (1) NZ753294A (es)
SA (1) SA519401755B1 (es)
WO (1) WO2018087554A1 (es)
ZA (1) ZA201902956B (es)

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4604283A (en) 1984-04-24 1986-08-05 Gresham Anne L Hoof conditioner and dressing and methods of use
US5891472A (en) 1996-11-19 1999-04-06 Meri Charmyne Russell Treatment of equine laminitis
US6028104A (en) 1997-01-30 2000-02-22 Ecolab Inc. Use of peroxygen compounds in the control of hairy wart disease
NL1008795C2 (nl) * 1998-04-02 1999-10-05 Rene Werenfridus Lodewijk Vroo Samenstelling voor het behandelen van hoeven en werkwijze voor het vervaardigen van de samenstelling.
TWI260220B (en) 1999-11-22 2006-08-21 Novartis Ag A pharmaceutical composition for the transdermal treatment of bacterial infections in animals
EP1272033B1 (de) * 2000-03-13 2004-06-09 Basf Aktiengesellschaft Agrotechnische formulierung
US6444707B1 (en) * 2000-08-22 2002-09-03 West Agro Topically applied hoof treatment composition and concentrate
US6663902B1 (en) 2000-09-19 2003-12-16 Ecolab Inc. Method and composition for the generation of chlorine dioxide using Iodo-Compounds, and methods of use
WO2008031104A2 (en) * 2006-09-08 2008-03-13 Delaval Holdings Ab Antimicrobial compositions and related applications
GB0720716D0 (en) 2007-10-23 2007-12-05 York Pharma Plc Novel formulation
US8703104B2 (en) 2007-10-25 2014-04-22 Ecolab Usa Inc Use of metal astringents for the treatment of hairy heel warts
AU2009308922B2 (en) * 2008-10-29 2016-04-14 Topaz Pharmaceuticals Inc. Preservative system for emulsion-based therapeutic topical formulations
JP2012510469A (ja) 2008-11-28 2012-05-10 アグロケム インコーポレイテッド 蹄病を治療するための組成物及び方法
US20140287064A1 (en) * 2009-04-28 2014-09-25 Karen G. Swenholt Compositions for improving the appearance and/or treating fungal infections of nails, mucus membranes and the integument
WO2010107482A2 (en) 2009-03-16 2010-09-23 Visions Marketing Group, Inc. Germicidal composition
US8974834B2 (en) 2010-01-15 2015-03-10 Ecolab Usa Inc. Method for producing reservoir layer for hoof treatment and reservoir layer
WO2012024324A1 (en) * 2010-08-16 2012-02-23 Delaval Holding Ab System and method for delivering germicidal agent to animal hoof
WO2014098759A1 (en) 2012-12-21 2014-06-26 Delaval Holding Ab Germicidal compositions comprising carboxylic acid mixture and use as topical disinfectants
US9750245B2 (en) 2013-03-08 2017-09-05 Laboratoire M2 Topical use of an antimicrobial formulation

Also Published As

Publication number Publication date
RU2019114202A (ru) 2020-12-10
BR112019009463A2 (pt) 2019-07-30
RU2019114202A3 (es) 2021-01-13
SA519401755B1 (ar) 2024-01-29
US12186284B2 (en) 2025-01-07
GB201908192D0 (en) 2019-07-24
CL2019001260A1 (es) 2019-09-13
US20200054577A1 (en) 2020-02-20
JP2019535711A (ja) 2019-12-12
US20220257530A1 (en) 2022-08-18
CA3043287A1 (en) 2018-05-17
GB2571235B (en) 2021-05-19
ZA201902956B (en) 2022-12-21
GB2571235A (en) 2019-08-21
US11344508B2 (en) 2022-05-31
WO2018087554A1 (en) 2018-05-17
NZ753294A (en) 2025-11-28
JP7058648B2 (ja) 2022-04-22
EP3538072A1 (en) 2019-09-18
CN110225746A (zh) 2019-09-10

Similar Documents

Publication Publication Date Title
CO2019000846A2 (es) Concentrados de recubrimiento no tóxicos para usos agrícolas
NI201400842A (es) Composiciones veterinarias orales parasiticidas que comprenden agentes activos de acción sistémica, métodos y usos de las mismas.
CL2019001565A1 (es) Composición farmacéutica para prevenir o tratar el cáncer, comprendiendo el polímorfo cristalino del hexoxido tetraarsénico.
UY36610A (es) Formulaciones inyectables de liberación extendida que comprenden un agente activo de isoxazolina, métodos y usos de las mismas
DOP2019000117A (es) Nuevos derivados de quinolina
CO2017008584A2 (es) Formulaciones inyectables de acción prolongada que comprenden un agente activo isoxazolina, métodos y usos de las mismas
MX2017007829A (es) Composicion antimicrobiana.
DOP2016000253A (es) Nuevos compuestos
BR112018001435A2 (pt) métodos para entrega linfática de agentes ativos
CL2019003025A1 (es) Concentrados espumantes agrícolas que contienen una amida lineal. (divisional solicitud 201603221)
MX2017004318A (es) Composiciones y metodos para el tratamiento y profilaxis de infecciones del sitio quirurgico.
CL2019001746A1 (es) Amidas aromáticas de ácido carboxílico
CL2016003258A1 (es) Composiciones parasiticidas que comprenden derivados de indol, métodos y usos de las mismas.
EP3610869A4 (en) Composition, containing sarpogrelate as active ingredient, for preventing or treating sensorineural hearing loss
MX2019001225A (es) Compuesto aromatico heterociclico nitrogenoso, metodo de preparacion del mismo, composicion farmaceutico del mismo y aplicacion del mismo.
MX2018002015A (es) Composicion de absorcion percutanea.
DOP2016000251A (es) Inhibidores de las vías de señalización de wnt
BR112018074905A2 (pt) composição para tratamento de planta
AR109407A1 (es) Compuesto de 1-acetil-3-fenilurea y su uso
AR109409A1 (es) Compuesto de 3-piridiloxifenildihidrouracilo y su uso
AR109406A1 (es) Compuesto de 1-fenil-3-carbamoilurea y su uso
CO2017007849A2 (es) Composición pesticida y método para controlar plagas
CL2019001260A1 (es) Formulaciones antimicrobianas para el tratamiento mejorado de infecciones veterinarias de pezuña
UY36273A (es) Composicion para el tratamiento de neuropatías y del dolor neuropático
EP3727397A4 (en) COMPOSITION AND METHOD OF TREATMENT, RELIEF OR PREVENTION OF NEUROPATHIC PAIN, WITH CHOLINAL FOSCERATE AS THE ACTIVE SUBSTANCE